Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
QSIthis companyQuantum-Si incorporated	$1.35	-2.16×	0.99×	89.3×	-2.15×	-92.1%	47.3%	-3996.7%	-4160.1%	-46.0%	-43.4%	-44.7%	0.02×	0.19×	0×	7.64×	0.0%	2	4.91	2	C+
ALTAltimmune, Inc.	$2.20	-3.61×	1.41×	7,757.46×	-3.56×	-96.0%	100.0%	-230461.0%	-214861.0%	-39.2%	-35.4%	-21.2%	0.16×	0.09×	-57.76×	18.55×	0.0%	2	2.76	2	C+
ANNXAnnexon, Inc.	$4.27	-3.75×	3.68×	0×	-3.14×	-80.0%	0.0%	0.0%	0.0%	-97.7%	-91.0%	-24.0%	0.12×	0.66×	0×	5.68×	0.0%	1	-1.2	2	C
AURAAura Biosciences, Inc.	$7.24	-3.1×	2.4×	0×	-2.73×	-88.8%	0.0%	0.0%	0.0%	-77.6%	-73.1%	-25.9%	0.13×	0.4×	0×	8.15×	0.0%	2	8.97	2	C+
LBRXLB Pharmaceuticals Inc Common Stock	$43.40	-22.26×	1.87×	0×	-12.72×	-75.2%	0.0%	0.0%	0.0%	-8.4%	-9.9%	-6.3%	0.01×	9.91×	0×	41.44×	0.0%	2	25.27	2	C+
RCKTRocket Pharmaceuticals, Inc.	$2.45	-1.75×	1.41×	0×	-1.6×	-80.8%	0.0%	0.0%	0.0%	-80.5%	-75.4%	-48.8%	0.09×	0.25×	-120.84×	6.38×	0.0%	1	-0.82	2	C+
Peer median	—	-3.61×	1.87×	0×	-3.14×	-80.8%	0.0%	0.0%	0.0%	-77.6%	-73.1%	-24.0%	0.12×	0.4×	0×	8.15×	0.0%	2	2.76	2	—